BioWorld MedTech

Nov. 26, 2013

3-D volume-rendered CT help assess risk of pitching injury

Professional baseball pitchers know that abusing pitching their arm can ruin their career. That's why pitch counts are important, especially for young players, pitchers recovering from injury or who have a history of pitching injuries. Read More

Medtronic: Growth hides emerging market slowdown

Smartphones, Xbox take control of medical devices

Washington roundup: CMS trims 1% from payments for 2014 home health schedule

Financings roundup: Pixium Vision raises €15M in Series A funding round

Genomic to license Alamac Group's technology

Boston Scientific gains approval for Promus Premier stent system

People in the News:

Briefly in the News:

Deals roundup: Denstply closes on QAHR, plans to acquire Triodent

Keeping you up to date on recent developments in cardiology:

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Roche reports new TREM2 agonists

BioWorld Science

F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...

Genescience presents STAT6 degrader for atopic dermatitis

BioWorld Science

Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....

Recludix’s first-in-class STAT6 inhibitor shows efficacy in atopic dermatitis

BioWorld Science

Researchers from Recludix Pharma Inc. reported preclinical efficacy data on REX-8756 (SAR-448755), a first-in-class orthosteric STAT6 inhibitor in models of...